Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04917_nanopub.RAzpnHpxHKLldbCfqBuc51sQ-WYb4y7SjxVxDxFQ6sK9k#assertion>. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB04917 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04917 label "Renzapride [drugbank:DB04917]" assertion.
- drugbank:DB04917 seeAlso DB04917 assertion.
- drugbank:DB04917 description "Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). It is also potentially effective for irritable bowel syndrome with alternating stool pattern (IBS-A). It is being developed by Alizyme of the UK. [Wikipedia]" assertion.
- drugbank:DB04917 identifier "drugbank:DB04917" assertion.
- drugbank:DB04917 title "Renzapride" assertion.
- drugbank:DB04917 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:3857873 assertion.
- drugbank:DB04917 drugbank_vocabulary:x-pubchemcompound pubchem.compound:3052778 assertion.
- drugbank:DB04917 drugbank_vocabulary:x-chemspider chemspider:2314555 assertion.
- drugbank:DB04917 drugbank_vocabulary:x-cas cas:112727-80-7 assertion.
- drugbank:DB04917 drugbank_vocabulary:drugbank-id "DB04917" assertion.
- drugbank:DB04917 bio2rdf_vocabulary:x-identifiers.org DB04917 assertion.
- drugbank:DB04917 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04917" assertion.
- drugbank:DB04917 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04917 bio2rdf_vocabulary:identifier "DB04917" assertion.
- drugbank:DB04917 drugbank_vocabulary:x-wikipedia wikipedia:Renzapride assertion.